The national drug agency has banned a wild clinical trial supposed to cure Alzheimer's and Parkinson's thanks to a molecule introduced in patches, and managed by the controversial professor Henri Joyeux, known for his battle against vaccines.

A clinical trial "wild", and therefore illegal, conducted on at least 350 Parkinson's or Alzheimer's disease has just been banned by the ANSM, the National Agency for the Safety of Medicines and Health Products. Tests conducted partly in an abbey near Poitiers by Josefa Fund structure, led by the controversial professor Henri Joyeux, known for his battle against vaccines.

"A risk to the health of the participants can not be excluded"

Patients were welcomed into the abbey for a patch containing a molecule that was supposed to treat their disease, before taking a blood test the next day. By inspecting the laboratory that analyzed the blood samples, the ANSM discovered the existence of these tests. "It's a breach of trust" for Bernard Celli, Director of Inspection at the Agence du médicament. "We do not know anything about this molecule, so a risk to the health of the participants can not be excluded," he says at the microphone of Europe 1. The ANSM has therefore requested the immediate cessation of this test " wild".

For his part, Professor Henri Joyeux denies the existence of "a wild clinical study". "Josefa Fund President Jean-Bernard Fourtillan has discovered a hormone that can be useful for patients, and I have confidence in his discovery," he insists. "So, I do not see what's coming out with this abbey, he found a place where it was cheap to do what he wanted to do, it's not a clinical study, it has nothing to do !".

But for the ANSM, which decided to seize justice, affected patients should no longer use these patches, and go see their doctor.